Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study
Ludbrook, V.J., Hicks, K.J., Hanrott, K.E., Patel, J.S., Binks, M.H., Wyres, M.R., Watson, J., Wilson, P., Simeoni, M., Schifano, L.A., Reich, K., Griffiths, C.E.M.
Published in British journal of dermatology (1951) (01.05.2016)
Published in British journal of dermatology (1951) (01.05.2016)
Get full text
Journal Article